Evidence map›Paper›PMID 27622562›Full record

ReviewPloS one2016

Cross-Country Individual Participant Analysis of 4.1 Million Singleton Births in 5 Countries with Very High Human Development Index Confirms Known Associations but Provides No Biologic Explanation for 2/3 of All Preterm Births.

David M Ferrero, Jim Larson, Bo Jacobsson, Gian Carlo Di Renzo, Jane E Norman, James N Martin, Mary D'Alton, Ernesto Castelazo, Chris P Howson, Verena Sengpiel and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 4 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 4 syntheses or guidelines pooled it, 197 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 13 institutions in 7 countries.

David M FerreroBoston Consulting Group, Boston, MA, United States of America.
Jim LarsonBoston Consulting Group, Boston, MA, United States of America.ORCID http://orcid.org/0000-0002-3814-2659
Bo JacobssonDepartment of Obstetrics and Gynecology, Institute for the Health of Women and Children, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Gian Carlo Di RenzoInternational Federation of Gynecology and Obstetrics, London, United Kingdom.
Jane E NormanTommy's Centre for Fetal and Maternal Health, Medical Research Council Centre for Reproductive Health, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
James N MartinDivision of Maternal-Fetal Medicine, University of Mississippi, Medical Center, Jackson, MS, United States of America.
Mary D'AltonDepartment of Obstetrics and Gynecology, Columbia University / College of Physicians and Surgeons, New York, NY, United States of America.
Ernesto CastelazoInternational Federation of Gynecology and Obstetrics, London, United Kingdom.
Chris P HowsonMarch of Dimes Foundation, White Plains, NY, United States of America.
Verena SengpielDepartment of Obstetrics and Gynecology, Institute for the Health of Women and Children, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Matteo BottaiUnit of Biostatistics, IMM, Karolinska Institutet, Stockholm, Sweden.
Jonathan A MayoDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States of America.
Gary M ShawDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States of America.
Ivan VerdenikDepartment of Perinatology, Division of Obstetrics and Gynecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Nataša TulDepartment of Perinatology, Division of Obstetrics and Gynecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Petr VelebilInstitute for the Care of Mother and Child, Perinatal Centre, Prague, Czech Republic.
Sarah Cairns-SmithBoston Consulting Group, Boston, MA, United States of America.
Hamid RushwanInternational Federation of Gynecology and Obstetrics, London, United Kingdom.
Sabaratnam ArulkumaranInternational Federation of Gynecology and Obstetrics, London, United Kingdom.
Jennifer L HowseMarch of Dimes Foundation, White Plains, NY, United States of America.
Joe Leigh SimpsonMarch of Dimes Foundation, White Plains, NY, United States of America.
Boston Consulting Group (United States)International Federation of Gynaecology and Obstetrics · GBMarch of Dimes · USLjubljana University Medical Centre · SIStanford University · USColumbia University · USKarolinska Institutet · SEMRC Centre for Reproductive Health · GBNorwegian Institute of Public Health · NOSahlgrenska University Hospital · SEUniversity of Mississippi Medical Center · USUniversity of Perugia · ITÚstav pro Péči o Matku a Dítě · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreterm birth is the most common single cause of perinatal and infant mortality, affecting 15 million infants worldwide each year with global rates increasing. Understanding of risk factors remains poor, and preventive interventions have only limited benefit. Large differences exist in preterm birth rates across high income countries. We hypothesized that understanding the basis for these wide variations could lead to interventions that reduce preterm birth incidence in countries with high rates. We thus sought to assess the contributions of known risk factors for both spontaneous and provider-initiated preterm birth in selected high income countries, estimating also the potential impact of successful interventions due to advances in research, policy and public health, or clinical practice.

methodsWe analyzed individual patient-level data on 4.1 million singleton pregnancies from four countries with very high human development index (Czech Republic, New Zealand, Slovenia, Sweden) and one comparator U.S. state (California) to determine the specific contribution (adjusting for confounding effects) of 21 factors. Both individual and population-attributable preterm birth risks were determined, as were contributors to cross-country differences. We also assessed the ability to predict preterm birth given various sets of known risk factors.

findingsPrevious preterm birth and preeclampsia were the strongest individual risk factors of preterm birth in all datasets, with odds ratios of 4.6-6.0 and 2.8-5.7, respectively, for individual women having those characteristics. In contrast, on a population basis, nulliparity and male sex were the two risk factors with the highest impact on preterm birth rates, accounting for 25-50% and 11-16% of excess population attributable risk, respectively (p<0.001). The importance of nulliparity and male sex on population attributable risk was driven by high prevalence despite low odds ratios for individual women. More than 65% of the total aggregated risk of preterm birth within each country lacks a plausible biologic explanation, and 63% of difference between countries cannot be explained with known factors; thus, research is necessary to elucidate the underlying mechanisms of preterm birth and, hence, therapeutic intervention. Surprisingly, variation in prevalence of known risk factors accounted for less than 35% of the difference in preterm birth rates between countries. Known risk factors had an area under the curve of less than 0.7 in ROC analysis of preterm birth prediction within countries. These data suggest that other influences, as yet unidentified, are involved in preterm birth. Further research into biological mechanisms is warranted.

conclusionsWe have quantified the causes of variation in preterm birth rates among countries with very high human development index. The paucity of explicit and currently identified factors amenable to intervention illustrates the limited impact of changes possible through current clinical practice and policy interventions. Our research highlights the urgent need for research into underlying biological causes of preterm birth, which alone are likely to lead to innovative and efficacious interventions.

Indexed as

CaliforniaCzech RepublicDatabases, FactualDeveloped CountriesFemaleHumansInfant, NewbornMaleMultivariate AnalysisNew ZealandPregnancyPremature BirthRegression AnalysisRisk FactorsSloveniaSweden

Identifiers

PMID27622562
PMCPMC5021369
OpenAlexW2518863280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.